(CNN Español) – The National Administration of Medicines, Food and Technology of Argentina (ANMAT) announces these markets that authorize the AstraZeneca emergency response register against covid-19.
Through a communication, the sanitary entity indicates that this vacancy is accompanied by “an acceptable benefit-risk balance”, which allows the registration of the registration. The authorization is for one year and will be subject to the condition of “sale receipt”.
MIRA: United Kingdom authorizes Oxford / AstraZeneca evacuation against covid-19 and implements new evacuation strategy
The ANMAT communication is to compile a risk management plan, in addition to communicating the advance information to the National Institute of Medicines (Iname).
Both these markets, the AstraZeneca vaccine and the University of Oxford were approved by the regulatory authorities of the United Kingdom, as they were first converted into the aval.
This is the third vacancy against the covid-19 that was authorized in Argentina, after Pfizer-BioNTech and Sputnik V, developed in Russia.
Argentina begins March to evacuate health personnel with the product acquired by Russia, Sputnik V.
MIRA: Argentina begins to apply Russian Sputnik V vaccine against covid-19
In March, the Argentine Ministry of Health confirmed 602,163 cases of covid-19 in 43,018 deaths involving the virus.